Neurocrine Biosciences Stock Income Statements

Neurocrine Biosciences Quarterly Income Statements Chart

Quarterly

Annual

Operating Profit

Net Income

Neurocrine Biosciences Quarterly Income Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31	2009-12-31	2009-09-30	2009-06-30	2009-03-31	2008-12-31	2008-09-30	2008-06-30	2008-03-31	2007-12-31	2007-09-30	2007-06-30	2007-03-31	2006-12-31	2006-09-30	2006-06-30	2006-03-31	2005-12-31	2005-09-30	2005-06-30	2005-03-31	2004-12-31	2004-09-30	2004-06-30	2004-03-31	2003-12-31	2003-09-30	2003-06-30	2003-03-31	2002-12-31	2002-09-30	2002-06-30	2002-03-31

revenues:
net product sales	682,000,000	563,700,000	616,600,000	583,800,000	509,000,000	507,200,000	491,800,000	446,300,000	415,300,000	259,075,000	379,300,000	352,000,000	305,000,000	196,650,000	288,800,000
collaboration revenues	5,500,000	8,900,000	5,500,000	6,400,000	6,300,000	4,625,000	7,000,000	6,400,000	5,100,000	10,100,000	8,600,000	26,200,000	5,600,000	8,725,000	7,200,000
total revenues	687,500,000	572,600,000	622,100,000	590,200,000	515,300,000	515,200,000	498,800,000	452,700,000	420,400,000	412,000,000	387,900,000	378,200,000	310,600,000	312,000,000	296,000,000	288,900,000	236,600,000	247,900,000	258,500,000	302,400,000	237,100,000	244,010,000	222,094,000	183,580,000	138,403,000	131,492,000	151,757,000	96,905,000	71,086,000	94,517,000	60,774,000	6,335,000					15,000,000				19,769,000					730,000	729,000	730,000	730,000	21,947,000	9,357,000	10,569,000	11,267,000	11,110,000	41,634,000	12,157,000	12,512,000	13,657,000	14,448,000	4,643,000	753,000	740,000	733,000	733,000	747,000	729,000	761,000	734,000	1,751,000	532,000	540,000	48,000	104,000	9,440,000	1,074,000	9,244,000	19,476,000	14,111,000	64,745,000	33,169,000	11,864,000	18,485,000	34,701,000	15,049,000	16,941,000
operating expenses:
cost of revenues	11,300,000	9,200,000	8,000,000	9,200,000	7,500,000	8,500,000	11,200,000	11,500,000	8,500,000	7,700,000	6,100,000	4,800,000	4,600,000
research and development	244,300,000	263,200,000	195,000,000	191,100,000	159,400,000	137,500,000	142,200,000	145,800,000	139,500,000	118,000,000	107,700,000	135,900,000	102,200,000	87,400,000	92,700,000	74,800,000	73,200,000	66,700,000	69,100,000	80,900,000	58,300,000	55,425,000	45,278,000	61,687,000	37,652,000	39,107,000	35,482,000	36,988,000	48,947,000	25,614,000	22,463,000	21,868,000	51,882,000	22,583,000	20,942,000	26,863,000	23,903,000	21,809,000	24,388,000	18,719,000	16,575,000	15,498,000	12,194,000	10,161,000	8,572,000	8,918,000	9,490,000	10,527,000	10,313,000	9,097,000	9,860,000	8,818,000	9,388,000	8,002,000	7,456,000	8,176,000	7,317,000	8,065,000	8,227,000	7,283,000	7,576,000	6,753,000	7,401,000	10,808,000	10,848,000	11,885,000	12,993,000	16,186,000	14,227,000	24,340,000	19,795,000	18,789,000	19,061,000	18,608,000	25,223,000	26,112,000	27,735,000	24,765,000	26,627,000	29,633,000	25,603,000	33,404,000	32,305,000	22,969,000	26,388,000	39,087,000	37,537,000		48,324,000	41,565,000	24,231,000	23,096,000	20,047,000
acquired in-process research and development		100,000	1,000,000	2,500,000	6,000,000				143,900,000					100,300,000		5,000,000			118,500,000	46,000,000		36,191,000		5,000,000	113,081,000
selling, general, and administrative	286,300,000	276,500,000	234,300,000
total operating expenses	541,900,000	549,000,000	438,300,000	444,800,000	416,000,000	364,900,000	357,600,000	379,100,000	534,600,000	308,600,000	300,100,000	323,500,000	307,500,000	348,300,000	251,500,000	226,100,000	205,100,000	176,100,000	302,800,000	225,800,000	178,200,000	195,289,000	131,996,000	149,119,000	239,400,000	109,621,000	97,434,000	98,757,000	108,533,000	82,683,000	66,769,000	63,603,000	79,932,000	46,251,000	38,436,000	41,828,000	35,857,000	30,748,000	35,844,000	25,322,000	22,057,000	20,468,000	16,857,000	14,361,000	12,725,000	12,260,000	12,735,000	13,897,000	13,705,000	13,365,000	13,319,000	11,949,000	13,059,000	10,663,000	11,194,000	11,061,000	10,573,000	13,786,000	11,982,000	10,533,000	10,922,000	9,720,000	10,456,000	16,576,000	19,871,000	31,444,000	16,465,000	20,851,000	22,513,000	129,126,000	29,366,000	27,596,000	27,378,000	25,703,000	41,270,000	38,508,000	47,070,000	38,705,000	39,624,000	39,421,000	31,211,000	39,669,000	37,732,000	28,438,000	31,671,000
operating income	145,600,000	23,600,000	183,800,000	145,400,000	99,300,000	150,300,000	141,200,000	73,600,000	-114,200,000	103,400,000	87,800,000	54,700,000	3,100,000	-36,300,000	44,500,000	62,800,000	31,500,000	71,800,000	-44,300,000	76,600,000	58,900,000	48,721,000	90,098,000	34,461,000	-100,997,000
yoy	46.63%	-84.30%	30.17%	97.55%	-186.95%	45.36%	60.82%	34.55%	-3783.87%	-384.85%	97.30%	-12.90%	-90.16%	-150.56%	-200.45%	-18.02%	-46.52%	47.37%	-149.17%	122.28%	-158.32%
qoq	516.95%	-87.16%	26.41%	46.42%	-33.93%	6.44%	91.85%	-164.45%	-210.44%	17.77%	60.51%	1664.52%	-108.54%	-181.57%	-29.14%	99.37%	-56.13%	-262.08%	-157.83%	30.05%	20.89%	-45.92%	161.45%	-134.12%
operating margin %
other income:
unrealized loss on equity investments	-6,700,000		-16,900,000
charges associated with convertible senior notes				-49,700,000	-88,700,000
investment income and other	20,600,000	21,700,000	23,400,000	22,800,000	23,400,000	20,000,000	15,600,000	12,000,000	9,800,000	8,400,000	200,000	1,600,000	1,000,000	700,000	800,000	900,000	1,400,000	1,600,000	2,700,000	3,600,000	4,700,000	5,229,000	4,797,000	4,607,000	4,576,000	4,700,000	4,113,000	3,347,000
total other income	13,900,000	-8,900,000	6,500,000	-46,800,000	-64,800,000	47,900,000	-25,600,000	48,000,000	10,900,000	14,500,000	10,100,000	-78,000,000	18,300,000	22,500,000	-14,000,000	-5,300,000	-4,300,000	-30,100,000	-12,800,000	6,600,000	-20,000,000	-10,083,000	-31,691,000	17,630,000	-1,597,000	-3,063,000	-3,559,000	-4,061,000	-4,371,000	-4,940,000	-5,130,000	-2,717,000	1,606,000	1,592,000	1,549,000	1,548,000	1,593,000	1,433,000	1,409,000	1,335,000	1,096,000	1,024,000	982,000	980,000	883,000	888,000	875,000	925,000	900,000	908,000	884,000	879,000	906,000	884,000	942,000	880,000	943,000	784,500	867,000	738,000	1,533,000				-541,000	1,861,000	-2,007,000	-854,000	-315,000	619,000	1,586,000	1,184,000	1,554,000	1,551,000	1,053,000	1,815,000	1,693,000	686,000	1,030,000	648,000	517,000	647,000	1,382,000	2,258,000	2,353,000
income before benefit from income taxes	159,500,000	14,700,000	190,300,000	98,600,000	34,500,000	198,200,000	115,600,000	121,600,000	-103,300,000	117,900,000	97,900,000	-23,300,000	21,400,000	-13,800,000	30,500,000	57,500,000	27,200,000	41,700,000	-57,100,000	83,200,000	38,900,000	38,638,000	58,407,000	52,091,000	-102,594,000
benefit from income taxes	52,000,000	6,800,000	60,500,000	33,600,000	-8,900,000	50,500,000	32,500,000	26,100,000		28,900,000	29,400,000		7,500,000	-6,500,000	8,000,000	15,200,000		1,400,000	500,000	3,600,000	1,500,000	4,638,000	4,618,000	753,000	-479,000
net income	107,500,000	7,900,000	129,800,000	65,000,000	43,400,000	147,700,000	83,100,000	95,500,000	-76,600,000	89,000,000	68,500,000	-16,900,000	13,900,000	-7,300,000	22,500,000	42,300,000	32,100,000	347,900,000	-57,600,000	79,600,000	37,400,000	34,000,000	53,789,000	51,338,000	-102,115,000	18,078,000	50,764,000	-5,913,000	-41,818,000	6,894,000	-11,125,000	-59,985,000	-78,326,000	-44,659,000	-36,887,000	-40,280,000	-19,264,000	-29,315,000	-34,435,000	-23,987,000	-1,192,000	-19,444,000	-15,875,000	-13,381,000	-11,842,000	-10,642,000	-11,131,000	-12,242,000	-12,075,000	9,490,000	-3,078,000	-501,000	-886,000	1,331,000	31,382,000	1,976,000	2,882,000	2,487,000	3,333,000	-5,152,000	-8,636,000	-7,916,000	-8,177,000	-15,280,000	-19,665,000	-28,854,000	-17,711,000	-20,971,000	-21,077,000	-127,975,000	-27,240,000	-26,364,000	-25,720,000	-14,712,000	-39,143,000	-27,449,000	-25,901,000	-23,908,000	26,151,000	-5,604,000	-18,830,000	-20,615,000	-1,647,000	-11,131,000	-12,380,000	3,193,000	-9,834,000	-10,225,000	-13,390,000	-38,787,000	-20,234,000	-19,751,000	-15,764,000
yoy	147.70%	-94.65%	56.20%	-31.94%	-156.66%	65.96%	21.31%	-665.09%	-651.08%	-1319.18%	204.44%	-139.95%	-56.70%	-102.10%	-139.06%	-46.86%	-14.17%	923.24%	-207.09%	55.05%	-136.63%	88.07%	5.96%	-968.22%	144.19%	162.23%	-556.31%	-90.14%	-46.61%	-115.44%	-69.84%	48.92%	306.59%	52.34%	7.12%	67.92%	1516.11%	50.77%	116.91%	79.26%	-89.93%	82.71%	42.62%	9.30%	-1.93%	-212.14%	261.63%	2343.51%	1262.87%	613.00%	-109.81%	-125.35%	-130.74%	-46.48%	841.55%	-138.35%	-133.37%	-131.42%	-140.76%	-66.28%	-56.08%	-72.57%	-53.83%	-27.14%	-6.70%	-77.45%	-34.98%	-20.46%	-18.05%	769.87%	-30.41%	-3.95%	-0.70%	-38.46%	-249.68%	389.81%	37.55%	15.97%	-1687.80%	-49.65%	52.10%	-745.63%	-83.25%	8.86%	-7.54%	-108.23%	-51.40%	-48.23%	-15.06%
qoq	1260.76%	-93.91%	99.69%	49.77%	-70.62%	77.74%	-12.98%	-224.67%	-186.07%	29.93%	-505.33%	-221.58%	-290.41%	-132.44%	-46.81%	31.78%	-90.77%	-703.99%	-172.36%	112.83%	10.00%	-36.79%	4.77%	-150.27%	-664.86%	-64.39%	-958.52%	-85.86%	-706.59%	-161.97%	-81.45%	-23.42%	75.39%	21.07%	-8.42%	109.09%	-34.29%	-14.87%	43.56%	1912.33%	-93.87%	22.48%	18.64%	13.00%	11.28%	-4.39%	-9.08%	1.38%	-227.24%	-408.32%	514.37%	-43.45%	-166.57%	-95.76%	1488.16%	-31.44%	15.88%	-25.38%	-164.69%	-40.34%	9.10%	-3.19%	-46.49%	-22.30%	-31.85%	62.92%	-15.55%	-0.50%	-83.53%	369.81%	3.32%	2.50%	74.82%	-62.41%	42.60%	5.98%	8.34%	-191.42%	-566.65%	-70.24%	-8.66%	1151.67%	-85.20%	-10.09%	-487.72%	-132.47%	-3.82%	-23.64%	-65.48%	91.69%	2.45%	25.29%
net income margin %
foreign currency translation adjustments, net of tax	800,000	1,500,000	2,900,000	100,000	-500,000	1,700,000	-1,400,000	900,000	1,200,000
unrealized gain on available-for-sale debt securities, net of tax	2,700,000	1,700,000	9,100,000																			884,500	961,000	878,000
comprehensive income	111,000,000	11,100,000	141,800,000	64,200,000	39,700,000	156,400,000	82,500,000	97,100,000	-71,400,000	95,100,000	66,700,000	-19,800,000	6,300,000	-9,400,000	22,200,000	42,000,000	31,300,000	346,500,000	-59,000,000	85,600,000	34,600,000	33,807,000	54,750,000	52,216,000		-2,805,971	51,517,000																							9,469,000	-2,916,000	-517,000	-926,000
earnings per share:
basic	1.09	0.08	1.28	0.64	0.43	0.263	0.85	0.98	-0.79	0.173	0.72	-0.18	0.15
diluted	1.06	0.08	1.24	0.63	0.42	0.253	0.82	0.95	-0.79	0.168	0.69	-0.18	0.14
weighted-average shares outstanding:
basic	99	99.7	101.1	100.8	99.8		97.9	97.6	97.1		95.8	95.6	95.3
diluted	101	102.5	104.3	103.9	103.6		101.1	100.2	97.1		99	95.6	97.6
unrealized gain on equity investments		-30,600,000
selling, general and administrative				242,000,000	243,100,000	218,900,000	204,200,000	221,800,000	242,700,000	182,900,000	186,300,000	182,800,000	200,700,000	156,500,000	154,600,000	143,200,000	129,000,000	106,500,000	112,500,000	96,500,000	117,800,000	63,212,750	84,489,000	80,824,000	87,538,000
unrealized gain on equity securities				-19,900,000						7,200,000	11,100,000	-7,400,000	19,900,000							11,300,000
unrealized gain on debt securities available-for-sale, net of tax				-900,000	-3,200,000	7,000,000	800,000	700,000	4,000,000					-350,000	-300,000	-300,000		450,000	-1,400,000	6,000,000	-2,800,000
interest expense					-1,100,000	-1,100,000	-1,100,000	-1,300,000	-1,100,000	-1,100,000	-1,200,000	-2,200,000	-2,600,000	-6,600,000	-6,600,000	-6,200,000	-6,400,000	-7,800,000	-8,500,000	-8,300,000	-8,200,000	-8,130,000	-8,038,000	-7,942,000	-7,853,000	-7,763,000	-7,672,000	-7,591,000	-7,504,000	-7,419,000	-7,337,000	-4,767,000																																		-1,437,250	-1,914,000	-1,914,000	-1,921,000	-636,250	-827,000	-848,000	-870,000	-893,000	-917,000	-943,000	-969,000	-996,000	-1,024,000	-1,054,000	-1,084,000	-1,054,000	-722,000	-185,000		2,000			-136,000	-118,000	-175,000	-91,000	-101,000
unrealized gain on equity security investments					1,600,000	-150,000	-40,100,000	37,300,000	2,200,000
loss on extinguishment of convertible senior notes												-70,000,000
(benefit from) benefit from income taxes									-26,700,000			-6,400,000					-4,900,000
unrealized loss on debt securities available-for-sale, net of tax										-3,075,000	-1,800,000	-2,900,000	-7,600,000				-800,000
cost of sales														4,100,000	4,200,000	3,100,000	2,900,000	2,900,000	2,700,000	2,400,000	2,100,000	2,462,000	2,229,000	1,608,000	1,129,000	1,534,000	1,551,000
gross profit
yoy
qoq
gross margin %
unrealized loss on equity securities														-1,875,000	-8,200,000			-3,050,000	-7,000,000
net income per share														0.258	0.24	0.45	0.34	3.74	-0.62	0.86	0.4	0.37	0.59	0.56	-1.12
weighted-average common shares outstanding, basic						97.7				95.8				94.6	94.7	94.6	94.2	93.1	93.3	93	92.6	91,627	91,859	91,389		90,235
weighted-average common shares outstanding, diluted						101				98.9				97.9	97.7	97.7	98.2	97.8	93.3	98.2	97	95,732	96,074	94,779		95,386
product sales																266,800,000	231,000,000	241,300,000	254,100,000	267,600,000	231,100,000	237,831,000	198,094,000	180,544,000	136,431,000	130,326,000	111,291,000	96,905,000	71,086,000	64,517,000	45,774,000	6,335,000
collaboration revenue																22,100,000	5,600,000	6,600,000	4,400,000	34,800,000	6,000,000	6,179,000	24,000,000	3,036,000	1,972,000	1,166,000	40,466,000
unrealized gain on restricted equity securities																	700,000							20,965,000
unrealized losses (gains) on equity securities																					-16,500,000
unrealized loss on restricted equity securities																						-7,182,000	-28,450,000
unrealized gain on investment in restricted equity securities																									1,680,000
unrealized gain on available-for-sale securities, net of tax																									1,699,000
comprehensive loss																									-100,416,000			-5,025,000	-43,665,000	5,578,000	-10,946,000	-60,463,000	-78,243,000	-44,790,000	-37,035,000	-40,131,000	-18,475,000	-29,683,000	-34,640,000	-24,212,000	-1,094,000	-10,327,500	-15,956,000	-13,313,000	-12,041,000	-8,863,750	-11,096,000	-12,242,000	-12,117,000
weighted-average common shares outstanding, basic and diluted																									91,056
sales, general and administrative																										68,980,000	60,401,000	60,915,000	58,636,000	56,309,000	43,873,000	41,674,000																																						10,786,000	9,571,000	8,807,000	8,317,000	7,095,000	16,047,000	12,396,000	19,335,000	13,940,000	12,997,000	9,788,000	5,608,000
income from operations																										21,871,000	54,323,000	-1,852,000	-37,447,000	11,834,000	-5,995,000	-57,268,000	-79,932,000	-46,251,000	-38,436,000	-41,828,000	-20,857,000	-30,748,000	-35,844,000	-25,322,000	-2,288,000	-20,468,000	-16,857,000	-14,361,000	-12,725,000	-11,530,000	-12,006,000	-13,167,000	-12,975,000	8,582,000	-3,962,000	-1,380,000	-1,792,000	447,000	30,440,000	1,096,000	1,939,000	-129,000	2,466,000	-5,890,000	-10,169,000	-8,980,000	-9,723,000	-15,843,000	-19,124,000	-30,715,000	-15,704,000	-20,117,000	-20,762,000	-128,594,000	-28,826,000	-27,548,000	-27,274,000	-16,263,000	-40,196,000	-29,264,000	-27,594,000	-24,594,000	25,121,000	-6,252,000	-19,347,000	-21,184,000	-3,031,000	-13,389,000	-14,730,000	-17,371,000	-13,574,000	-12,490,000	-15,352,000	-41,273,000	-22,501,000	-22,020,000	-17,821,000
net income per common share:
basic																										-29.77	560																							150	-50	-10	-10	20	570	40	50	-50	60															-615	-1,030			12.5	710											-457.5	-660
diluted																										-29.78	520																							150	-50	-10	-10	30	560	40	50	-50	60															-615	-1,030			12.5	680											-457.5	-660
shares used in the calculation of net income per common share:
basic																										22,516,000	90,555,000																							264,000	66,342,000	66,309,000	63,409,000	28,000	55,248,000	55,209,000	54,983,000	13,032,500	54,844,000															9,416,000	37,868,000			9,171,250	36,707,000											7,611,750	30,522,000
diluted																										23,818,000	96,798,000																							1,591,000	66,342,000	66,309,000	63,409,000	38,000	56,378,000	56,434,000	56,114,000	13,032,500	55,648,000															9,416,000	37,868,000			9,498,000	38,406,000											7,611,750	30,522,000
other comprehensive income:
net unrealized gain on available-for-sale securities																										-51,500	753,000	888,000
cost of product sales																												854,000	950,000	760,000	433,000	61,000
deferred gain on real estate																												183,000	201,000	183,000	183,000	879,000	879,000	863,000	853,000	854,000	853,000	838,000	828,000	829,000	830,000	812,000	805,000	805,000	804,000	789,000	781,000	781,000	782,000	766,000	759,000	759,000	758,000	744,000	736,000	737,000	736,000	722,000	715,000	715,000				694,000	695,000
net income per common share:
basic and diluted																												-70	-470	-425	-130	-680	-900	-277.5	-430	-460	-220	-177.5	-400	-280	-10	-140	-210	-180	-170	-132.5	-170	-180	-180											-90	-190	-190	-210	-390	-510	-740	-460	-550	-550	-3,360	-720	-690	-680			-730	-690			-150	-510	-560	-50	-310	-350	-0.268	-0.31		-430			-650
shares used in the calculation of net income per common share:
basic and diluted																												90,100,000	89,526,000	21,973,500	88,325,000	88,063,000	87,283,000	21,664,750	86,784,000	86,694,000	86,497,000	20,981,750	85,856,000	85,518,000	80,349,000	18,512,500	75,948,000	75,879,000	70,260,000	16,717,000	67,199,000	66,799,000	66,600,000											54,836,000	46,618,000	199,000	39,096,000	39,046,000	38,669,000	50,000	38,446,000	38,421,000	38,330,000	53,000	37,990,000	37,969,000	37,908,000			37,764,000	37,355,000			36,647,000	36,598,000	93,000	36,427,000	36,368,000	35,527,000	32,342,603	32,053		30,789,000			30,433,000	30,384,000
other comprehensive loss:
investment income																													2,932,000	2,323,000	2,019,000	1,169,000	727,000	716,000	705,000	680,000	737,000	584,000	581,000	506,000	257,000	197,000	176,000	167,000	89,000	85,000	93,000	121,000	103,000	130,000	123,000	115,000	121,000	85,250	102,000		119,000
net unrealized gains on available-for-sale securities																													-1,847,000				83,000				789,000					-70,000	-81,000	68,000		14,000	35,000			-21,000	162,000	-16,000
license fees and milestones																														3,750,000	15,000,000			3,750,000			15,000,000																					3,331,250	9,238,000	3,357,000	730,000	547,500	730,000	730,000	730,000	797,250	729,000	730,000	1,730,000	125,000	500,000			1,702,750	726,000	727,000	5,358,000	21,836,000	55,448,000	25,448,000	6,448,000	12,450,750	26,096,000	12,388,000		7,326,500	11,319,000
other income, net:
gain/(loss) on sale/disposal of assets																														1,750	5,000							2,250
net unrealized gains/(losses) on available-for-sale securities																														-54,000	179,000			197,500	-148,000	149,000					98,000
gain on sale/disposal of assets																																2,000			-9,000	14,000	3,000				9,000		1,000	5,000	-10,000	-1,000	6,000	19,000	13,000	7,000			25,000	58,000	86,000	18,000	80,000	92,000	34,000	53,000	115,000	2,893,000	571,000	21,000	141,000
net unrealized (losses)/gains on available-for-sale securities																																-478,000								-225,000
general and administrative																																	28,050,000	23,668,000	17,494,000	14,965,000	11,954,000	8,939,000	11,456,000	6,603,000	5,482,000	4,970,000	4,663,000	4,200,000	4,153,000	3,342,000	3,245,000	3,370,000	3,392,000	3,311,000	3,324,000	3,131,000	3,671,000	2,668,000	3,825,000	2,809,000	3,156,000	3,323,000	3,635,000	3,116,000	3,199,000	2,841,000	2,966,000	4,827,000	4,195,000	4,105,750	3,472,000	4,665,000	8,286,000													6,265,000	5,427,000	5,469,000	5,283,000	5,419,000	5,296,000		4,744,000	3,586,000	3,253,000	3,151,000	2,731,000
license fees																																						4,942,250			19,769,000					547,250	729,000	730,000	730,000																																				11,319,000				6,667,000	436,750	581,000	583,000	583,000
other income																																										15,000		3,000		15,000	-5,000	4,000	2,000	5,000	2,000	5,000	2,000	5,000	18,000	5,000	8,000	996,000		35,000	24,000	1,188,000	111,000	-558,000	-283,000									-118,000	-472,000							-136,000	2,000						48,000
net unrealized losses on available-for-sale securities																																						-83,000	-205,000						-199,000				-42,000				-40,000
sponsored research and development																																																		13,959,000	1,369,000	1,540,000	2,029,000	1,873,000	2,396,000	2,919,000	3,274,000	4,419,000	5,210,000	1,286,000	23,000	11,000	3,000	3,000	17,000	-1,000	32,000	4,000	12,000	19,000	13,000	21,000	86,000	213,000	348,000	277,000	5,878,000	753,000	1,297,000	2,721,000	4,416,000	10,676,000	8,605,000	2,506,000	5,369,000	15,048,000	17,580,000		30,725,000	1,652,000	3,574,000	3,180,000	3,958,000
cease-use expense																																																		957,000	135,000			-7,000	-87,000	76,000	100,000				147,000				4,828,000
milestones and license fees																																																		7,988,000	7,988,000	9,029,000	9,238,000	9,237,000	39,238,000	9,238,000	9,238,000
investment income and (expense)																																																								120,000		183,000	118,000	-65,000
cease use expense																																																										100,250	120,000	134,000		1,464,500	89,000	941,000
deferred gain on sale of real estate																																																													715,000	521,000	694,000
investment income and																																																													679,000
grant revenue																																																																		2,250			9,000	18,000	27,000	27,000	18,000
other income and
gain on auction rate securities																																																														-286,750	71,000	230,000
interest income																																																														157,250	99,000	176,000	354,000									1,972,000	2,442,000	2,758,000	2,662,000	1,645,000	2,080,000	1,713,000	1,601,000	1,837,000	2,102,000	2,444,000	2,353,000	2,599,000	3,724,000		2,201,000	2,564,000	2,458,000	2,282,000	2,045,000
total other income net																																																														392,000	1,546,000	563,000
loss on auction rate securities																																																																	-1,448,000
interest income and other income																																																																		643,250	-93,000	1,060,000	1,606,000	1,717,250	2,413,000	2,032,000	2,424,000
sales force allowance																																																																												8,240,000	8,240,000	8,000,000	8,000,000	5,000,000
other income and (expense)																																																																														-9,250	-26,000	-11,000				-1,000		30,750	19,000
grant income																																																																																				155,000	253,000	246,500	360,000		324,000	364,500	578,000	464,000
income before income taxes																																																																														429,250	26,151,000	-5,604,000		-6,289,250	-1,649,000	-11,131,000		-8,323,250	-9,831,000	-10,223,000
income taxes																																																																																		78,000	-2,000			2,000	3,000	2,000
sales allowance																																																																																	1,000,000
interest income and
income before income tax expense																																																																																	-18,830,000				-12,377,000				-13,239,000
income tax expense																																																																																					3,000				151,000
net income per share														0.258	0.24	0.45	0.34	3.74	-0.62	0.86	0.4	0.37	0.59	0.56	-1.12
basic and diluted																												-70	-470	-425	-130	-680	-900	-277.5	-430	-460	-220	-177.5	-400	-280	-10	-140	-210	-180	-170	-132.5	-170	-180	-180											-90	-190	-190	-210	-390	-510	-740	-460	-550	-550	-3,360	-720	-690	-680			-730	-690			-150	-510	-560	-50	-310	-350	-0.268	-0.31		-430			-650
shares used in the calculation of net income per share:
basic and diluted																												90,100,000	89,526,000	21,973,500	88,325,000	88,063,000	87,283,000	21,664,750	86,784,000	86,694,000	86,497,000	20,981,750	85,856,000	85,518,000	80,349,000	18,512,500	75,948,000	75,879,000	70,260,000	16,717,000	67,199,000	66,799,000	66,600,000											54,836,000	46,618,000	199,000	39,096,000	39,046,000	38,669,000	50,000	38,446,000	38,421,000	38,330,000	53,000	37,990,000	37,969,000	37,908,000			37,764,000	37,355,000			36,647,000	36,598,000	93,000	36,427,000	36,368,000	35,527,000	32,342,603	32,053		30,789,000			30,433,000	30,384,000
net income per common share:
shares used in the calculation of net
loss per common share:
milestones																																																																																										62,500	250,000
other income and (expenses)																																																																																										43,750	-16,000	78,000
grant income and other revenues																																																																																													416,000
other income and expenses																																																																																													113,000
loss per common share:
basic and diluted																																																																																													-520
shares used in the calculation of loss per common share:
basic and diluted																												90,100,000	89,526,000	21,973,500	88,325,000	88,063,000	87,283,000	21,664,750	86,784,000	86,694,000	86,497,000	20,981,750	85,856,000	85,518,000	80,349,000	18,512,500	75,948,000	75,879,000	70,260,000	16,717,000	67,199,000	66,799,000	66,600,000											54,836,000	46,618,000	199,000	39,096,000	39,046,000	38,669,000	50,000	38,446,000	38,421,000	38,330,000	53,000	37,990,000	37,969,000	37,908,000			37,764,000	37,355,000			36,647,000	36,598,000	93,000	36,427,000	36,368,000	35,527,000	32,342,603	32,053		30,789,000			30,433,000	30,384,000

We provide you with 20 years income statements for Neurocrine Biosciences stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Neurocrine Biosciences stock. Explore the full financial landscape of Neurocrine Biosciences stock with our expertly curated income statements.

The information provided in this report about Neurocrine Biosciences stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.